Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 9—September 2017
CME ACTIVITY - Research

Epidemiology of Salmonella enterica Serotype Dublin Infections among Humans, United States, 1968–2013

R. Reid Harvey1, Cindy R. Friedman, Stacy M. Crim, Michael Judd, Kelly A. Barrett, Beth Tolar, Jason P. Folster, Patricia M. Griffin, and Allison C. BrownComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 3

Percentage of patients with adverse clinical outcomes after infection with Salmonella enterica serotype Dublin, United States, 1996–2004 and 2005–2013. *p<0.05 (significant difference).

Figure 3. Percentage of patients with adverse clinical outcomes after infection with Salmonella enterica serotype Dublin, United States, 1996–2004 and 2005–2013. *p<0.05 (significant difference).

Main Article

1Current affiliation: Centers for Disease Control and Prevention, Morgantown, WV, USA.

Page created: August 15, 2017
Page updated: August 15, 2017
Page reviewed: August 15, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external